- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Gabelli Healthcare & WellnessRx Trust(GRX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GRX
11/13/2026: GRX (2-star) has a low Upturn Star Rating. Not recommended to BUY.
Gabelli Healthcare & WellnessRx Trust is a non-diversified, closed-end investment fund that provides investors with active exposure to the healthcare and wellness sectors. Its primary strength lies in the management team's research-intensive approach, which targets undervalued companies with long-term growth potential. The main investment story centers on capturing value from advancements in biotechnology, digital health, and wellness consumer trends. However, investors must consider risks such as potential NAV discounts, sector-specific regulatory pressures, and competition from lower-cost passive alternatives. This stock may suit value-oriented investors seeking consistent distributions, provided they monitor the fund's discount levels and the performance of the underlying healthcare equity holdings.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | The fund focuses on long-term capital appreciation, though active management introduces performance variance. |
| Momentum investor | Weak fit | This is a fundamental-based, long-term vehicle, not suited for short-term momentum strategies. |
| Value investor | Strong fit | The Gabelli investment philosophy is rooted in finding undervalued companies, which aligns with value-oriented strategies. |
| Dividend investor | Strong fit | The fund provides consistent distributions, making it suitable for income-seeking investors. |
| Low-risk investor | Weak fit | Equity market exposure and the potential use of leverage make this unsuitable for low-risk, capital preservation goals. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As an equity-focused fund, share price and NAV can fluctuate significantly with market sentiment. |
| Valuation risk | Medium | The fund can trade at a discount or premium to NAV, affecting investor entry and exit points. |
| Competition risk (sector ETF competition) | Medium | Low-cost passive alternatives continue to attract assets away from actively managed closed-end funds. |
| Business quality | Medium | The fund's performance is tied to the quality of the individual healthcare and wellness stocks selected. |
| Dividend income | Medium | Distributions are dependent on underlying portfolio performance and may not always be sustainable. |
| Execution risk | Medium | The investment team's ability to pick winners in the volatile healthcare sector is critical to long-term success. |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 151.41M USD | Price to earnings Ratio 18.26 | 1Y Target Price - |
Price to earnings Ratio 18.26 | 1Y Target Price - | ||
Volume (30-day avg) 18.2K shares | Beta - | 52 Weeks Range 8.54 - 10.64 | Updated Date 11/14/2026 |
52 Weeks Range 8.54 - 10.64 | Updated Date 11/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.57 |
Sector & Industry Intelligence
Sector
Financial Services
Constructive- Sentiment
- Bullish
- Momentum
- BUY Breadth Improving
- BUY participation
- 50.4%
- Active BUY / eligible
- 61 / 121
- 30-Day BUY Count Change
- +45
- Market state
- Bullish
More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.
Industry
Asset Management
- BUY participation
- 52.9%
- Active BUY / eligible
- 9 / 17
- 30-Day BUY Count Change
- +3
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type Stock | Historic Profit 21.77% | Avg. Invested days 52 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Investment Portfolio | Capital gains, dividends, and interest from a portfolio of healthcare and wellness equities. | The fund generates returns primarily through the stock performance and dividends of the companies it owns. |
| Geographic Exposure | Global equity markets with a primary focus on US-listed healthcare and wellness companies. | The fund is largely exposed to the US market, which is the hub for much of global healthcare innovation. |
Valuation
Trailing PE 18.26 | Forward PE - | Enterprise Value - | Price to Sales(TTM) 18.12 |
Enterprise Value - | Price to Sales(TTM) 18.12 | ||
Enterprise Value to Revenue 17.09 | Enterprise Value to EBITDA - | Shares Outstanding 14.54M | Shares Floating - |
Shares Outstanding 14.54M | Shares Floating - | ||
Percent Insiders 1.77 | Percent Institutions 42.02 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

